Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

Tourmaline Oil Corp. engages in the acquisition, exploration, development, and production of petroleum and natural gas properties in the Western Canadian Sedimentary Basin. It holds interests in ...

Canadian Natural Resources (CNQ) is in talks to buy a $1B-plus portfolio of natural gas properties in Alberta from Tourmaline Oil (TRMLF), the Globe and Mail reported Wednesday. Canada's biggest shale ...

Our Tourmaline Oil Corp. stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. Assess the Tourmaline Oil stock price estimates. View ...

As a social gathering place, and center of a community, the parking lot and beach at the end of Tourmaline Street is something to be cherished -- old friends, old stories, old boards, and a brand-new ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Tourmaline Oil Corp. is an oil and natural gas company, which engages in the acquisition, exploration, development, and production of petroleum and natural gas properties. It focuses on its program in ...

Tourmaline is Canada's largest and most active natural gas producer dedicated to producing the lowest-development-cost natural gas in North America. We are an investment grade exploration and ...

Tourmaline went public in 2023 via a reverse merger with the struggling cell therapy developer Talaris. The deal gave Tourmaline funds to develop pacibekitug, an antibody that targets interleukin-6, a ...

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...